Inhibition of ENG expression on myCAFs not only suppressed the TGF‐β–Smad2/3 pathway and TGF‐β1 expression but also attenuated the ability of myCAF to promote primary tumor growth and metastasis. The gene discussed is SMAD2; the disease is neoplasm.